Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancers

Collin M. Blakely(City College of San Francisco), Trever G. Bivona(University of California, San Francisco)
bioRxiv (Cold Spring Harbor Laboratory)
March 16, 2017
10.1101/117291
Cited by 2

Related Papers

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
|Journal of Thoracic Oncology|2018|661
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|459
Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution
|Cell|2022|339
Targeting Oncogenic BRAF: Past, Present, and Future
|Cancers|2019|241